Cardiovascular disease risk associated with asthma and respiratory morbidity might be mediated by short-acting β2-agonists

Studies are required to elucidate how asthma exposes older women to excess macrovascular risk and prospectively determine the short-acting β2-agonist-related risk in persons without existing CVD. CVD risk in relation to atopic status of asthma also requires further investigation.